232 related articles for article (PubMed ID: 16475992)
21. HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.
Simula MP; Caggiari L; Gloghini A; De Re V
Ann N Y Acad Sci; 2007 Sep; 1110():121-30. PubMed ID: 17911427
[TBL] [Abstract][Full Text] [Related]
22. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
23. Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.
Sansonno D; Lauletta G; Nisi L; Gatti P; Pesola F; Pansini N; Dammacco F
Clin Exp Immunol; 2003 Aug; 133(2):275-82. PubMed ID: 12869035
[TBL] [Abstract][Full Text] [Related]
24. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects.
Gaud U; Langer B; Petropoulou T; Thomas HC; Karayiannis P
J Med Virol; 2003 Mar; 69(3):350-6. PubMed ID: 12526045
[TBL] [Abstract][Full Text] [Related]
25. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus.
Sene D; Ghillani-Dalbin P; Thibault V; Guis L; Musset L; Duhaut P; Poynard T; Piette JC; Cacoub P
J Rheumatol; 2004 Nov; 31(11):2199-206. PubMed ID: 15517633
[TBL] [Abstract][Full Text] [Related]
26. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.
Gragnani L; Piluso A; Giannini C; Caini P; Fognani E; Monti M; Petrarca A; Ranieri J; Razzolini G; Froio V; Laffi G; Zignego AL
Arthritis Rheum; 2011 May; 63(5):1446-51. PubMed ID: 21538321
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.
Saadoun D; Landau DA; Calabrese LH; Cacoub PP
Rheumatology (Oxford); 2007 Aug; 46(8):1234-42. PubMed ID: 17566058
[TBL] [Abstract][Full Text] [Related]
28. [Cryoglobulinemia and hepatitis C virus infection].
Garini G; Catellani W; Manganelli P; Buzio C
Recenti Prog Med; 2001 Jan; 92(1):54-62. PubMed ID: 11260973
[TBL] [Abstract][Full Text] [Related]
29. Mixed cryoglobulinemia and hepatitis C virus infection.
Lunel F; Musset L
Minerva Med; 2001 Feb; 92(1):35-42. PubMed ID: 11317137
[TBL] [Abstract][Full Text] [Related]
30. B-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection.
Fabris M; Quartuccio L; Sacco S; De Marchi G; Pozzato G; Mazzaro C; Ferraccioli G; Migone TS; De Vita S
Rheumatology (Oxford); 2007 Jan; 46(1):37-43. PubMed ID: 16735452
[TBL] [Abstract][Full Text] [Related]
31. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.
De Vita S; De Re V; Gasparotto D; Ballarè M; Pivetta B; Ferraccioli G; Pileri S; Boiocchi M; Monteverde A
Arthritis Rheum; 2000 Jan; 43(1):94-102. PubMed ID: 10643704
[TBL] [Abstract][Full Text] [Related]
32. Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study.
Nagasaka A; Takahashi T; Sasaki T; Takimoto K; Miyashita K; Nakamura M; Wakahama O; Nishikawa S; Higuchi A
J Med Virol; 2001 Sep; 65(1):52-7. PubMed ID: 11505443
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
[TBL] [Abstract][Full Text] [Related]
34. Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients.
De Re V; Pavan A; Sansonno S; Sansonno D; Racanelli V
Ann N Y Acad Sci; 2009 Sep; 1173():326-33. PubMed ID: 19758169
[TBL] [Abstract][Full Text] [Related]
35. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia.
Fayyazi A; Schott P; Hartmann H; Mihm S; Middel P; Ramadori G; Radzun HJ
Z Gastroenterol; 1997 Oct; 35(10):921-8. PubMed ID: 9370142
[TBL] [Abstract][Full Text] [Related]
36. Cerebral ischemic attack secondary to hepatitis C virus infection.
Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
[TBL] [Abstract][Full Text] [Related]
37. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia.
Saadoun D; Sellam J; Ghillani-Dalbin P; Crecel R; Piette JC; Cacoub P
Arch Intern Med; 2006 Oct; 166(19):2101-8. PubMed ID: 17060540
[TBL] [Abstract][Full Text] [Related]
38. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.
Hartmann H; Schott P; Polzien F; Mihm S; Uy A; Kaboth U; Pardowitz I; Ramadori G
Z Gastroenterol; 1995 Nov; 33(11):643-50. PubMed ID: 8600660
[TBL] [Abstract][Full Text] [Related]
39. Using evolutionary tools to refine the new hypervariable region 3 within the envelope 2 protein of hepatitis C virus.
Torres-Puente M; Cuevas JM; Jiménez-Hernández N; Bracho MA; García-Robles I; Wrobel B; Carnicer F; del Olmo J; Ortega E; Moya A; González-Candelas F
Infect Genet Evol; 2008 Jan; 8(1):74-82. PubMed ID: 18063425
[TBL] [Abstract][Full Text] [Related]
40. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
